3-乙氧基-4-羟基苯乙酸 | 80018-50-4

• 物质功能分类: 有机原料 - 羧酸类化合物及衍生物
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 中文名称: 3-乙氧基-4-羟基苯乙酸
• 英文名称: [3-(ethyloxy)-4-hydroxyphenyl]acetic acid
• 英文别名: 3-ethoxy-4-hydroxyphenylacetic acid；2-(3-ethoxy-4-hydroxyphenyl)acetic acid
• CAS: 80018-50-4
• 化学式: C₁₀H₁₂O₄
• mdl: MFCD00016835
• 分子量: 196.203
• InChiKey: QVXSHYZATYQYGE-UHFFFAOYSA-N

物化性质

• 熔点：
  90-92°C
• 沸点：
  376.4±27.0 °C(Predicted)
• 密度：
  1.259±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  14
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  66.8
• 氢给体数：
  2
• 氢受体数：
  4

安全信息

• 危险等级：
  IRRITANT
• 危险品标志：
  Xi
• 安全说明：
  S26,S36/37/39
• 危险类别码：
  R36/37/38
• 海关编码：
  2918990090

反应信息

• 作为反应物：
  描述：

  3-乙氧基-4-羟基苯乙酸 在 N,N-二异丙基乙胺 、 N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate 作用下， 以 四氢呋喃 为溶剂， 反应 4.0h， 生成
  参考文献：
  名称：

  Cell-Based Selection Expands the Utility of DNA-Encoded Small-Molecule Library Technology to Cell Surface Drug Targets: Identification of Novel Antagonists of the NK3 Tachykinin Receptor

  摘要：

  DNA-encoded small-molecule library technology has recently emerged as a new paradigm for identifying ligands against drug targets. To date, this technology has been used with soluble protein targets that are produced and used in a purified state. Here, we describe a cell-based method for identifying small-molecule ligands from DNA-encoded libraries against integral membrane protein targets. We use this method to identify novel, potent, and specific inhibitors of NK3, a member of the tachykinin family of G-protein coupled receptors (GPCRs). The method is simple and broadly applicable to other GPCRs and integral membrane proteins. We have extended the application of DNA-encoded library technology to membrane-associated targets and demonstrate the feasibility of selecting DNA-tagged, small-molecule ligands from complex combinatorial libraries against targets in a heterogeneous milieu, such as the surface of a cell.

  DOI：

  10.1021/acscombsci.5b00124
• 作为产物：
  描述：

  邻乙氧基苯酚 在 盐酸 、 tin(ll) chloride 、 sodium hydroxide 作用下， 生成 3-乙氧基-4-羟基苯乙酸
  参考文献：
  名称：

  Design, synthesis, and evaluation of phenylpiperazine-phenylacetate derivatives as rapid recovery hypnotic agents

  摘要：

  DOI：

  10.1016/j.bmcl.2021.128497

文献信息

• Indoline derivatives
  申请人：Dittrich-Wengenroth Elke

  公开号：US20070197626A1

  公开（公告）日：2007-08-23

  The present invention relates to novel indoline derivatives, to processes for their preparation and to their use in medicaments, in particular as potent PPAR-delta-activating compounds for the prophylaxis and/or treatment of cardiovascular disorders, in particular of dyslipidaemias, arteriosclerosis and coronary heart diseases.

  本发明涉及新型吲哚啉衍生物，以及它们的制备过程和在药物中的应用，特别是作为强效PPAR-δ激活化合物，用于预防和/或治疗心血管疾病，特别是血脂异常、动脉硬化和冠心病。
• Short-acting sedative hypnotic agents for anesthesia and sedation
  申请人：——

  公开号：US20030153554A1

  公开（公告）日：2003-08-14

  The invention provides compounds compositions and methods useful for inducing or maintaining general anesthesia or sedation in mammals.

  这项发明提供了一种用于在哺乳动物中诱导或维持全身麻醉或镇静的化合物组合物和方法。
• 4-methylcatechol Derivatives and Uses Thereof
  申请人：THANARES GMBH

  公开号：US20160347782A1

  公开（公告）日：2016-12-01

  The invention relates to phenoxy derivatives with glycosidically bound sugar moieties, pharmaceutical compositions containing such compounds, uses of such compounds and compositions, and methods of making such compounds and pharmaceutical compositions.

  这项发明涉及具有糖苷键结合的苯氧基衍生物，包含这些化合物的药物组合物，这些化合物和组合物的用途，以及制备这些化合物和药物组合物的方法。
• Synthesis and Evaluation of 4-Hydroxyphenylacetic Acid Amides and 4-Hydroxycinnamamides as Antioxidants
  作者：Young-Sik Jung、Tae-Souk Kang、Joong-Ho Yoon、Bo-Young Joe、Hee-Jong Lim、Churl-Min Seong、Woo-Kyu Park、Jae-Yang Kong、Jungsook Cho、No-Sang Park

  DOI：10.1016/s0960-894x(02)00479-1

  日期：2002.9

  acid amides and 4-hydroxycinnamamides were synthesized and their antioxidant and neuroprotective activities were evaluated. Among the prepared compounds, 8b, and exhibited potent inhibition of lipid peroxidation in rat brain homogenates, and marked DPPH radical scavenging activities. Furthermore, and exhibited neuroprotective action against the oxidative damage induced by the exposure of primary cultured

  合成了4-羟基苯基乙酸酰胺和4-羟基肉桂酰胺，并评估了它们的抗氧化和神经保护活性。在制备的化合物中，8b在大鼠脑匀浆中显示出对脂质过氧化的有效抑制作用，并具有明显的DPPH自由基清除活性。此外，并表现出针对主要培养的大鼠皮层细胞暴露于H（2）O（2），黄嘌呤/黄嘌呤氧化酶或Fe（2 +）/抗坏血酸引起的氧化损伤的神经保护作用。根据这些结果，我们发现它是所测试化合物中最有效的抗氧化剂。
• [EN] COMPOUNDS AS S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS<br/>[FR] COMPOSÉS EN TANT QU'INHIBITEURS DE LA S-NITROSOGLUTATHION RÉDUCTASE
  申请人：N30 PHARMACEUTICALS LLC

  公开号：WO2012170371A1

  公开（公告）日：2012-12-13

  The present invention is directed to compounds useful as S-nitrosoglutathione reductase (GSNOR) inhibitors, pharmaceutical compositions comprising such compounds, and methods of making and using the same.

  本发明涉及用作S-亚硝基谷胱甘肽还原酶（GSNOR）抑制剂的化合物，包括该化合物的制药组合物以及使用该化合物的方法。

表征谱图